Literature DB >> 27209499

Supply and Demand for Radiation Oncology in the United States: Updated Projections for 2015 to 2025.

Hubert Y Pan1, Bruce G Haffty2, Benjamin P Falit3, Thomas A Buchholz1, Lynn D Wilson4, Stephen M Hahn1, Benjamin D Smith5.   

Abstract

PURPOSE: Prior studies have forecasted demand for radiation therapy to grow 10 times faster than the supply between 2010 and 2020. We updated these projections for 2015 to 2025 to determine whether this imbalance persists and to assess the accuracy of prior projections. METHODS AND MATERIALS: The demand for radiation therapy between 2015 and 2025 was estimated by combining current radiation utilization rates determined by the Surveillance, Epidemiology, and End Results data with population projections provided by the US Census Bureau. The supply of radiation oncologists was forecast by using workforce demographics and full-time equivalent (FTE) status provided by the American Society for Radiation Oncology (ASTRO), current resident class sizes, and expected survival per life tables from the US Centers for Disease Control.
RESULTS: Between 2015 and 2025, the annual total number of patients receiving radiation therapy during their initial treatment course is expected to increase by 19%, from 490,000 to 580,000. Assuming a graduating resident class size of 200, the number of FTE physicians is expected to increase by 27%, from 3903 to 4965. In comparison with prior projections, the new projected demand for radiation therapy in 2020 dropped by 24,000 cases (a 4% relative decline). This decrease is attributable to an overall reduction in the use of radiation to treat cancer, from 28% of all newly diagnosed cancers in the prior projections down to 26% for the new projections. By contrast, the new projected supply of radiation oncologists in 2020 increased by 275 FTEs in comparison with the prior projection for 2020 (a 7% relative increase), attributable to rising residency class sizes.
CONCLUSION: The supply of radiation oncologists is expected to grow more quickly than the demand for radiation therapy from 2015 to 2025. Further research is needed to determine whether this is an appropriate correction or will result in excess capacity.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27209499     DOI: 10.1016/j.ijrobp.2016.02.064

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

1.  Are there enough radiation oncologists to lead the new Spanish radiotherapy?

Authors:  A Rodríguez; M Arenas; P C Lara; J López-Torrecilla; M Algara; A Conde; H Pérez-Montero; J L Muñoz; P Peleteiro; M J Pérez-Calatayud; J Contreras; C Ferrer
Journal:  Clin Transl Oncol       Date:  2019-04-03       Impact factor: 3.405

2.  Radiation oncology residency selection: A postgraduate evaluation of factor importance and survey of variables associated with job securement.

Authors:  Jeffrey V Brower; Stanley L Liauw; Abhinav V Reddy; Daniel W Golden
Journal:  Pract Radiat Oncol       Date:  2017-04-26

3.  Patterns of stereotactic body radiation therapy: The influence of lung cancer treatment on prostate cancer treatment.

Authors:  Bruce L Jacobs; Jonathan G Yabes; Samia H Lopa; Dwight E Heron; Chung-Chou H Chang; Justin E Bekelman; Joel B Nelson; Julie P W Bynum; Amber E Barnato; Jeremy M Kahn
Journal:  Urol Oncol       Date:  2019-11-05       Impact factor: 3.498

Review 4.  Enhancing Career Paths for Tomorrow's Radiation Oncologists.

Authors:  Neha Vapiwala; Charles R Thomas; Surbhi Grover; Mei Ling Yap; Timur Mitin; Lawrence N Shulman; Mary K Gospodarowicz; John Longo; Daniel G Petereit; Ronald D Ennis; James A Hayman; Danielle Rodin; Jeffrey C Buchsbaum; Bhadrasain Vikram; May Abdel-Wahab; Alan H Epstein; Paul Okunieff; Joel Goldwein; Patrick Kupelian; Joanne B Weidhaas; Margaret A Tucker; John D Boice; Clifton David Fuller; Reid F Thompson; Andrew D Trister; Silvia C Formenti; Mary-Helen Barcellos-Hoff; Joshua Jones; Kavita V Dharmarajan; Anthony L Zietman; C Norman Coleman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-05-22       Impact factor: 7.038

Review 5.  Artificial intelligence in radiation oncology.

Authors:  Elizabeth Huynh; Ahmed Hosny; Christian Guthier; Danielle S Bitterman; Steven F Petit; Daphne A Haas-Kogan; Benjamin Kann; Hugo J W L Aerts; Raymond H Mak
Journal:  Nat Rev Clin Oncol       Date:  2020-08-25       Impact factor: 66.675

6.  Domestic Job Shortage or Job Maldistribution? A Geographic Analysis of the Current Radiation Oncology Job Market.

Authors:  Mudit Chowdhary; Arpit M Chhabra; Jeffrey M Switchenko; Jaymin Jhaveri; Neilayan Sen; Pretesh R Patel; Walter J Curran; Ross A Abrams; Kirtesh R Patel; Gaurav Marwaha
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-24       Impact factor: 7.038

7.  IBPRO - A Novel Short-Duration Teaching Course in Advanced Physics and Biology Underlying Cancer Radiotherapy.

Authors:  Michael C Joiner; Monica W Tracey; Sara E Kacin; Jay W Burmeister
Journal:  Radiat Res       Date:  2017-03-22       Impact factor: 2.841

Review 8.  The future of personalised radiotherapy for head and neck cancer.

Authors:  Jimmy J Caudell; Javier F Torres-Roca; Robert J Gillies; Heiko Enderling; Sungjune Kim; Anupam Rishi; Eduardo G Moros; Louis B Harrison
Journal:  Lancet Oncol       Date:  2017-04-26       Impact factor: 41.316

9.  Attitudes and access to resources and strategies to improve quality of radiotherapy among US radiation oncologists: A mixed methods study.

Authors:  Y Helen Zhang; Elaine Cha; Kathleen Lynch; Renee Gennarelli; Jeffrey Brower; Michael V Sherer; Daniel W Golden; Susan Chimonas; Deborah Korenstein; Erin F Gillespie
Journal:  J Med Imaging Radiat Oncol       Date:  2022-06-01       Impact factor: 1.667

10.  Clinical and sociodemographic factors that affect the quality of life of survivors of head and neck cancer.

Authors:  Laura Izabel Lampert Bonzanini; Eloisa Barbieri Soldera; Gabriela Barbieri Ortigara; Riéli Elis Schulz; Raquel Pippi Antoniazzi; Thiago Machado Ardenghi; Kívia Linhares Ferrazzo
Journal:  Support Care Cancer       Date:  2019-08-02       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.